Home Healthcare IT Glucose Monitoring Devices Market Size, CAGR of 9.8%, Top Share, Forecast to 2032

Glucose Monitoring Devices Market Size, Share & Trends Analysis Report By Product (Self-monitoring Devices, Continuous Blood Glucose Monitoring Devices), By End-User (Hospitals, Home Care, Diagnostic Centers) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRHI178DR
Author : Debashree Bora

Table Of Content

  1. Executive Summary

    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends

    1. Global Glucose Monitoring Devices Market Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Self-monitoring Devices
        1. By Value
      3. Continuous Blood Glucose Monitoring Devices
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Home Care
        1. By Value
      4. Diagnostic Centers
        1. By Value
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Self-monitoring Devices
        1. By Value
      3. Continuous Blood Glucose Monitoring Devices
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Home Care
        1. By Value
      4. Diagnostic Centers
        1. By Value
    4. U.S.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Self-monitoring Devices
          1. By Value
        3. Continuous Blood Glucose Monitoring Devices
          1. By Value
      2. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Home Care
          1. By Value
        4. Diagnostic Centers
          1. By Value
    5. Canada
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Self-monitoring Devices
        1. By Value
      3. Continuous Blood Glucose Monitoring Devices
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Home Care
        1. By Value
      4. Diagnostic Centers
        1. By Value
    4. U.K.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Self-monitoring Devices
          1. By Value
        3. Continuous Blood Glucose Monitoring Devices
          1. By Value
      2. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Home Care
          1. By Value
        4. Diagnostic Centers
          1. By Value
    5. Germany
    6. France
    7. Spain
    8. Italy
    9. Russia
    10. Nordic
    11. Benelux
    12. Rest of Europe
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Self-monitoring Devices
        1. By Value
      3. Continuous Blood Glucose Monitoring Devices
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Home Care
        1. By Value
      4. Diagnostic Centers
        1. By Value
    4. China
      1. By Product
        1. Introduction
          1. Product By Value
        2. Self-monitoring Devices
          1. By Value
        3. Continuous Blood Glucose Monitoring Devices
          1. By Value
      2. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Home Care
          1. By Value
        4. Diagnostic Centers
          1. By Value
    5. Korea
    6. Japan
    7. India
    8. Australia
    9. Singapore
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Self-monitoring Devices
        1. By Value
      3. Continuous Blood Glucose Monitoring Devices
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Home Care
        1. By Value
      4. Diagnostic Centers
        1. By Value
    4. UAE
      1. By Product
        1. Introduction
          1. Product By Value
        2. Self-monitoring Devices
          1. By Value
        3. Continuous Blood Glucose Monitoring Devices
          1. By Value
      2. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Home Care
          1. By Value
        4. Diagnostic Centers
          1. By Value
    5. Turkey
    6. Saudi Arabia
    7. South Africa
    8. Egypt
    9. Nigeria
    10. Rest of MEA
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Self-monitoring Devices
        1. By Value
      3. Continuous Blood Glucose Monitoring Devices
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Home Care
        1. By Value
      4. Diagnostic Centers
        1. By Value
    4. Brazil
      1. By Product
        1. Introduction
          1. Product By Value
        2. Self-monitoring Devices
          1. By Value
        3. Continuous Blood Glucose Monitoring Devices
          1. By Value
      2. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Home Care
          1. By Value
        4. Diagnostic Centers
          1. By Value
    5. Mexico
    6. Argentina
    7. Chile
    8. Colombia
    9. Rest of LATAM
    1. Glucose Monitoring Devices Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Abbott Laboratories
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. F. Hoffmann-La Roche Ltd
    3. Medtronic plc
    4. Ascensia Diabetes Care
    5. Ypsomed Holdings
    6. Dexcom, Inc.
    7. Sanofi
    8. Novo Nordisk
    9. Insulet Corporation
    10. Glysens Incorporated
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Blood Pressure Monitoring Devices Market Size The global blood pressure monitoring devices market size was valued at USD 3.67 billion in 2024 and is projected to reach from USD 4.02 billion in 2025 to USD 8.37
Buy Now
Global Report
Remote Patient Monitoring Devices Market Size The global remote patient monitoring devices market size was valued at USD 21.13 billion in 2024. It is estimated to reach USD 25.09 billion in 2025 to USD 98.87 billion in 2033, growing a
Buy Now
Global Report
The global vital signs monitoring devices market size was valued at USD 5,156.5 million in 2019 and is expected to grow at a CAGR of 8.5% during the forecast period, (2020–2031). Factors such as Rising Popularity of Home-Bas
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report


We are featured on :